Pinnbrook Capital Management LP acquired a new position in shares of Ventas, Inc. (NYSE:VTR – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 81,200 shares of the real estate investment trust’s stock, valued at approximately $7,211,000.
Other large investors also recently made changes to their positions in the company. Deutsche Bank AG grew its holdings in Ventas by 0.7% during the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after purchasing an additional 27,688 shares in the last quarter. Bank of New York Mellon Corp increased its stake in Ventas by 2.5% during the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock worth $222,000,000 after buying an additional 70,459 shares during the period. Norges Bank acquired a new position in Ventas in the 4th quarter worth $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Ventas by 7.4% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after buying an additional 92,236 shares in the last quarter. Finally, Cbre Investment Management Listed Real Assets LLC boosted its position in Ventas by 5.8% in the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust’s stock valued at $143,305,000 after buying an additional 101,370 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.
Ventas Trading Up 0.7%
NYSE VTR opened at $93.32 on Friday. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The company has a market capitalization of $47.87 billion, a price-to-earnings ratio of 172.81, a price-to-earnings-growth ratio of 2.15 and a beta of 0.69. The company’s fifty day moving average price is $91.36 and its two-hundred day moving average price is $87.08.
Insider Activity at Ventas
In other news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.53% of the company’s stock.
Analyst Ratings Changes
Several analysts have recently weighed in on VTR shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $100.00 target price on shares of Ventas in a research note on Tuesday, June 16th. UBS Group increased their price target on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Royal Bank Of Canada raised their price objective on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research note on Friday, August 14th. Scotiabank dropped their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. Finally, Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. Fifteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $98.00.
Get Our Latest Analysis on Ventas
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Read More
- Five stocks we like better than Ventas
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
